Kevin Michael Donahue insider trades

Open-market stock purchases and sales by Kevin Michael Donahue, 10% Owner at Mainz Biomed NV, from SEC Form 4 filings since Oct 17, 2025.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -72%.

Recent trades

DateStockTradeValue
Oct 17, 2025MYNZ Mainz Biomed NVBought$259B
Oct 17, 2025MYNZ Mainz Biomed NVBought$1M

Companies traded

  • MYNZ Mainz Biomed NV: 2 buys, last Oct 17, 2025

Get free alerts when Kevin Michael Donahue files a new trade →